Gladstone Scientists Recommend Renewed Focus on ApoE as Target for Halting Alzheimer's Disease
Scientists at the Gladstone Institutes, which is affiliated with UCSF, are recommending a shift in efforts to treat Alzheimer’s disease by developing drugs that target the apoE4 protein, which has long been associated with an increased risk for the disease.
![Placeholder image](/themes/custom/ucsf/images/card/transparent-news-card.png)